Efficacy of folic acid therapy on the progression of chronic kidney disease: The renal substudy of the China stroke primary prevention trial

JAMA Internal Medicine

Volumn 176, Issue 10, 2016, Pages 1443-1450

  Xu, Xin ^a   Qin, Xianhui ^a   Li, Youbao ^a   Sun, Danhua ^a   Wang, Jun ^a   Liang, Min ^a   Wang, Binyan ^a   Huo, Yong ^b   Hou, Fan Fan ^a   Cao, Kejiang ^w   Chen, Luyuan ^w   Cheng, Xiaoshu ^w   Cui, Yimin ^w   Dong, Qiang ^w   Ge, Junbo ^w   Gao, Pingjin ^w   Gao, Runlin ^w   Hu, Dayi ^w   Ji, Xunming ^w   Li, Jianping ^w   Li, Nanfang ^w   Li, Xiaoying ^w   Liu, Lisheng ^w   Ma, Changsheng ^w   Sun, Ningling ^w   Wang, Jian'an ^w   Wang, Wen ^w   Wang, Xian ^w   Xiao, Chuanshi ^w   Yang, Xinchun ^w   Zhu, Dingliang ^w   Zhao, Gang ^w   Zhao, Lianyou ^w   Li, Yong ^c   Li, Xiangming ^d   Wan, Yan Luan ^e   Tan, Jingzhi ^f   Dong, Shuhong ^g   Xu, Hongtuan ^h   Liu, Jiahong ⁱ   Xu, Jian ^j   Li, Daogang ^k   Liu, Changyin ^l   Xu, Jinbo ^m   Liu, Chunlei ⁿ   Xu, Libo ^o   Zhou, Zhong ^p   Zhou, Zhenchao ^q   Liu, Shuyong ^r   Tang, Chungen ^s   Xu, Zongpan ^t   Xiong, Zhenggen ^u   Zhu, Xinyan ^v   more..

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

^c Anfeng Township Central Hospital   (China)

^d Baita Township Hospital   (China)

^e Banzhuang Township Central Hospital   (China)

^f Chengtou Township Hospital   (China)

^g Ganma Township Hospital   (China)

^h Haitou Township Central Hospital   (China)

ⁱ Henggou Rural Hospital   (China)

^j Huandun Township Hospital   (China)

^k Huangchuan Township Central Hospital   (China)

^l Linian Rural Hospital   (China)

^m Lizhuang Township Hospital   (China)

ⁿ Qinghu Township Central Hospital   (China)

^o Shahe Township Central Hospital   (China)

^p Shanzuokou Rural Hospital   (China)

^q Shilianghe Rural Hospital   (China)

^r Shiliu Township Hospital   (China)

^s Shuangdian Township Hospital   (China)

^t Taolin Township Central Hospital   (China)

^u Tashan Township Hospital   (China)

^v Tuofeng Township Hospital   (China)

^w NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL; FOLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG COMBINATION; HOMOCYSTEINE; VITAMIN B COMPLEX;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CAUSE OF DEATH; CHINESE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOTHERAPY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; BLOOD; CHINA; DRUG COMBINATION; GLOMERULUS FILTRATION RATE; KIDNEY FAILURE, CHRONIC;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHINA; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ENALAPRIL; FEMALE; FOLIC ACID; GLOMERULAR FILTRATION RATE; HOMOCYSTEINE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; VITAMIN B COMPLEX;

EID: 84997078143     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2016.4687     Document Type: Article

References (27)

1. Collins AJ, Foley RN, Chavers B, et al. US Renal Data System 2013 Annual Data Report. Am J Kidney Dis. 2014;63(1)(suppl):A7.
2. Peralta CA, Shlipak MG, Judd S, et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA. 2011;305(15):1545-1552.
3. Sarnak MJ, Levey AS, Schoolwerth AC, et al; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003; 42(5):1050-1065.
4. Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815-822.
5. Drawz PE, Rosenberg ME. Slowing progression of chronic kidney disease. Kidney Int Suppl (2011). 2013;3(4):372-376.
6. Meguid El Nahas A, Bello AK. Chronic kidney disease: the global challenge. Lancet. 2005;365 (9456):331-340.
7. Mills KT, Xu Y, Zhang W, et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88(5):950-957.
8. Marti F, Vollenweider P, Marques-Vidal PM, et al. Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study. BMC Public Health. 2011;11:733.
9. Ponte B, Pruijm M, Marques-Vidal P, et al. Determinants and burden of chronic kidney disease in the population-based CoLaus study: a cross-sectional analysis. Nephrol Dial Transplant. 2013;28(9):2329-2339.
10. Jager A, Kostense PJ, Nijpels G, et al. Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study. Arterioscler Thromb Vasc Biol. 2001;21(1): 74-81.
11. Ninomiya T, Kiyohara Y, Kubo M, et al. Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study. Am J Kidney Dis. 2004;44(3):437-445.
12. House AA, Eliasziw M, Cattran DC, et al. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA. 2010;303(16):1603-1609.
13. Jamison RL, Hartigan P, Kaufman JS, et al; Veterans Affairs Site Investigators. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA. 2007;298(10):1163-1170.
14. Qin X, Huo Y, Langman CB, et al. Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: ameta-analysis. Clin J Am Soc Nephrol. 2011;6(3):482-488.
15. Qin X, Huo Y, Xie D, Hou F, Xu X, Wang X. Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: ameta-analysis of randomized controlled trials. Clin Nutr. 2013;32(5): 722-727.
16. Huo Y, Li J, Qin X, et al; CSPPT Investigators. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA. 2015;313 (13):1325-1335.
17. Jardine MJ, Kang A, Zoungas S, et al. The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis. BMJ. 2012;344:e3533.
18. Myung SK, Ju W, Cho B, et al; Korean Meta-Analysis Study Group. Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. BMJ. 2013;346:f10.
19. Levey AS, Stevens LA, Schmid CH, et al; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9):604-612.
20. Systolic Blood Pressure Intervention Trial (SPRINT) protocol. November 1, 2012 (https://www.sprinttrial.org/public/Protocol-Current.pdf).
21. Lv J, Ehteshami P, Sarnak MJ, et al. Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis. CMAJ. 2013;185(11): 949-957.
22. Sarnak MJ, Greene T, Wang X, et al. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med. 2005;142(5):342-351.
23. Hou W, Lv J, Perkovic V, et al. Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. Eur Heart J. 2013;34(24): 1807-1817.
24. Shurraw S, Hemmelgarn B, Lin M, et al; Alberta Kidney Disease Network. Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study. Arch Intern Med. 2011;171(21):1920-1927.
25. Pfeiffer CM, Sternberg MR, Fazili Z, et al. Unmetabolized folic acid is detected in nearly all serum samples from US children, adolescents, and adults. J Nutr. 2015;145(3):520-531.
26. Spence JD, Eliasziw M, House AA. B-vitamin therapy for diabetic Nephropathy [Reply]. JAMA. 2010;304:636-637.
27. Spence JD. Metabolic B12 deficiency: a missed opportunity to prevent dementia and stroke. Nutr Res. 2016;36(2):109-116. doi:10.1016/j.nutres.2015.10.003.